These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19966863)

  • 1. Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) mice.
    Koehl GE; Spitzner M; Ousingsawat J; Schreiber R; Geissler EK; Kunzelmann K
    Oncogene; 2010 Mar; 29(10):1553-60. PubMed ID: 19966863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J; Hargest R; Wasan H; Phillips RK
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
    Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
    Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice.
    Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A
    Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of colonic ion channels in APC ( Min/+ ) mice.
    Ousingsawat J; Spitzner M; Schreiber R; Kunzelmann K
    Pflugers Arch; 2008 Aug; 456(5):847-55. PubMed ID: 18247045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between K-rasVal12 and mutant Apc accelerates murine large intestinal tumourigenesis.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Arends MJ
    Oncol Rep; 2011 Jul; 26(1):125-33. PubMed ID: 21573497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations.
    Oshima M; Oshima H; Kobayashi M; Tsutsumi M; Taketo MM
    Cancer Res; 1995 Jul; 55(13):2719-22. PubMed ID: 7796392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of Min and Mom1 on neoplasia in ectopic intestinal grafts.
    Gould KA; Dove WF
    Cell Growth Differ; 1996 Oct; 7(10):1361-8. PubMed ID: 8891340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
    Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
    Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways.
    Mabley JG; Pacher P; Bai P; Wallace R; Goonesekera S; Virag L; Southan GJ; Szabó C
    Mutat Res; 2004 Apr; 548(1-2):107-16. PubMed ID: 15063141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal expression of ERalpha and ERbeta is associated with estrogen-mediated modulation of intestinal tumorigenesis.
    Weyant MJ; Carothers AM; Mahmoud NN; Bradlow HL; Remotti H; Bilinski RT; Bertagnolli MM
    Cancer Res; 2001 Mar; 61(6):2547-51. PubMed ID: 11289129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiposity-related protection of intestinal tumorigenesis: interaction with dietary calcium.
    Ding S; McEntee MF; Whelan J; Zemel M
    Nutr Cancer; 2007; 58(2):153-61. PubMed ID: 17640161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice.
    Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K
    Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
    Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
    J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
    Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
    Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.